Investing, US News

AstraZeneca’s Antibody Cocktail Only 33 Percent Effective at Preventing Covid Symptoms

NASDAQ:AZN NMA COVID vaccine distribution vaccine trial results testing sites Scalia osha Health companies Julie Gerberding coronavirus wuhan lab accident

Following the mixed success of its vaccine, AstraZeneca Plc (NASDAQ:AZN) faces another blow as its long-acting antibody cocktail AZD7442 failed to prevent symptoms in 33% of people exposed to the SARS-CoV-2 virus in a preliminary study. Q1 2021 hedge fund letters, conferences and more More than 1,100 adults volunteered for the trial in both the […]

The post AstraZeneca’s Antibody Cocktail Only 33 Percent Effective at Preventing Covid Symptoms appeared first on ValueWalk.

Jump To The Original Source

Facebook Comments

Check Also

Mets rally for walk-off win; Javier Baez homers in debut

Published by New York Daily News NEW YORK ...

Archives